Biome Australia Ltd (AU:BIO) has released an update.
Biome Australia Limited has issued over 3.7 million new shares following the exercise of options, falling under an exemption that allows these shares to be traded without standard disclosure, as stipulated by section 708A(5) of the Corporations Act 2001. The company, known for developing and marketing clinically-supported probiotics and complementary medicines, ensures there is no pertinent undisclosed information that would affect an investor’s assessment of the shares’ value. Biome continues to expand its reach both locally and internationally, emphasizing its commitment to improving health outcomes with its Activated Probiotics product line.
For further insights into AU:BIO stock, check out TipRanks’ Stock Analysis page.
